caffeic acid phenethyl ester has been researched along with b 844-39 in 1 studies
| Studies (caffeic acid phenethyl ester) | Trials (caffeic acid phenethyl ester) | Recent Studies (post-2010) (caffeic acid phenethyl ester) | Studies (b 844-39) | Trials (b 844-39) | Recent Studies (post-2010) (b 844-39) |
|---|---|---|---|---|---|
| 840 | 1 | 469 | 13 | 0 | 12 |
| Protein | Taxonomy | caffeic acid phenethyl ester (IC50) | b 844-39 (IC50) |
|---|---|---|---|
| Potassium channel subfamily K member 2 | Bos taurus (cattle) | 0.75 | |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 6.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bennis, K; Ducki, S; Lesage, F; Vivier, D | 1 |
1 review(s) available for caffeic acid phenethyl ester and b 844-39
| Article | Year |
|---|---|
Perspectives on the Two-Pore Domain Potassium Channel TREK-1 (TWIK-Related K(+) Channel 1). A Novel Therapeutic Target?
Topics: Arrhythmias, Cardiac; Depression; Epilepsy; Humans; Inflammation; Models, Molecular; Molecular Structure; Neuroprotective Agents; Pain; Potassium Channels, Tandem Pore Domain; Structure-Activity Relationship | 2016 |